PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/109519 https://doi.org/10.4321/s1886-36552014000200005 |
Resumo: | Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach’s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen’s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a wellstructured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients’ monitoring and in the screening of adverse effects. |
id |
RCAP_24a9450253e6aedfbd17aa14625e7fbd |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/109519 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugsPersyve - Diseño y validación de un cuestionario sobre efectos adversos de antihipertensivosAntihypertensive AgentsDrug-Related Side Effects and Adverse ReactionsMedication AdherenceQuestionnairesValidation Studies as TopicPortugalAntihipertensivosEfectos colaterales de y reacciones adversas de los medicamentos;Cumplimiento de la MedicaciónCuestionariosEstudios de Validación como AsuntoPortugalObjective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach’s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen’s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a wellstructured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients’ monitoring and in the screening of adverse effects.Objetivo: El objetivo de este estudio fue diseñar y validar un cuestionario para medir los síntomas percibidos asicados a medicamentos antihipertensivos (PERSYVE). Métodos: El desarrollo y validación de PERSYVE incluyó cuatro etapas: 1) desarrollo de ítems (revisión bibliográfica y elaboración del cuestionario); 2) validación de rostro y de contenido; 3) prueba de campo (pre-test); y 4) validación test-retest, evaluación de la consistencia interna (alfa de Chronbach) y reproductibilidad en el tiempo (coeficiente de correlación intra-clases y coeficiente kappa de Cohen). Resultados: De acuerdo con los resultados obtenidos de la revisión de la literatura, PERSYVE se divide en seis secciones: (1) adherencia a medicamentos, (2) síntomas percibidos y como afectan a la calidad de vida (escala Likert de cinco puntos), (3) comunicación con los profesionales de la salud, (4) percepción de síntomas como reacciones adversas, (5) influencia en el cumplimiento del tratamiento, y (6) adopción de métodos no farmacológicos para el control de la presión arterial. La validación de rostro y de contenido del cuestionario llevaron a algunos cambios de vocabulario y a la introducción de la sección 2.1. El ensayo de campo (n=26) reveló una alta comprensibilidad de las preguntas. El alfa de Cronbach calculado para la sección 2 (escala de Likert de 5 puntos) fue de 0,850. PERSYVE fue reproducible (n=167): valores de kappa presentaron una reproductibilidad sustancial y, en la sección 2, los valores de ICC resultaron de buenos a excelentes. Conclusión: Los resultados demostraron que PERSYVE es un cuestionario bien estructurado, objetivo, fácil de usar para el paciente, válido y confiable. PERSYVE puede ser un instrumento muy útil en la monitorización de pacientes hipertensos y en el rastreo de efectos adversos.Centro de Investigaciones y Publicaciones Farmaceuticas2014-04info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/109519http://hdl.handle.net/10316/109519https://doi.org/10.4321/s1886-36552014000200005eng1885-642XDuarte-Silva, DanielaFigueiras, AdolfoHerdeiro, Maria TeresaTeixeira Rodrigues, AntónioBranco, Fábio SilvaPolónia, JorgeFigueiredo, Isabel V.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-18T11:27:13Zoai:estudogeral.uc.pt:10316/109519Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:25:42.231222Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs Persyve - Diseño y validación de un cuestionario sobre efectos adversos de antihipertensivos |
title |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs |
spellingShingle |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs Duarte-Silva, Daniela Antihypertensive Agents Drug-Related Side Effects and Adverse Reactions Medication Adherence Questionnaires Validation Studies as Topic Portugal Antihipertensivos Efectos colaterales de y reacciones adversas de los medicamentos; Cumplimiento de la Medicación Cuestionarios Estudios de Validación como Asunto Portugal |
title_short |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_full |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_fullStr |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_full_unstemmed |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs |
title_sort |
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs |
author |
Duarte-Silva, Daniela |
author_facet |
Duarte-Silva, Daniela Figueiras, Adolfo Herdeiro, Maria Teresa Teixeira Rodrigues, António Branco, Fábio Silva Polónia, Jorge Figueiredo, Isabel V. |
author_role |
author |
author2 |
Figueiras, Adolfo Herdeiro, Maria Teresa Teixeira Rodrigues, António Branco, Fábio Silva Polónia, Jorge Figueiredo, Isabel V. |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Duarte-Silva, Daniela Figueiras, Adolfo Herdeiro, Maria Teresa Teixeira Rodrigues, António Branco, Fábio Silva Polónia, Jorge Figueiredo, Isabel V. |
dc.subject.por.fl_str_mv |
Antihypertensive Agents Drug-Related Side Effects and Adverse Reactions Medication Adherence Questionnaires Validation Studies as Topic Portugal Antihipertensivos Efectos colaterales de y reacciones adversas de los medicamentos; Cumplimiento de la Medicación Cuestionarios Estudios de Validación como Asunto Portugal |
topic |
Antihypertensive Agents Drug-Related Side Effects and Adverse Reactions Medication Adherence Questionnaires Validation Studies as Topic Portugal Antihipertensivos Efectos colaterales de y reacciones adversas de los medicamentos; Cumplimiento de la Medicación Cuestionarios Estudios de Validación como Asunto Portugal |
description |
Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach’s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen’s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a wellstructured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients’ monitoring and in the screening of adverse effects. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-04 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/109519 http://hdl.handle.net/10316/109519 https://doi.org/10.4321/s1886-36552014000200005 |
url |
http://hdl.handle.net/10316/109519 https://doi.org/10.4321/s1886-36552014000200005 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1885-642X |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Centro de Investigaciones y Publicaciones Farmaceuticas |
publisher.none.fl_str_mv |
Centro de Investigaciones y Publicaciones Farmaceuticas |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134138918240256 |